Addressing polypharmacy and comorbidities If you take several medications, have them all reviewed before starting GLP-1 therapy
In obese patients without diabetes, their use was linked to a significantly lower incidence and progression of primary open-angle glaucoma (POAG) and ocular hypertension compared to other weight-loss drugs [102]
Off-label use may seem dangerous, but its only done when a drug has been shown to be effective in medical literature and the class of drugs already has FDA approval for another purpose
In some cases, though, mixing supplements is okay, and sometimes even encouraged
doi: 10.1016/j.bbrc.2017.06.031, 104 NauckM
And if I think like, oh, this is like cardiovascular disease, then then we need to be focusing there, not waiting until things change